A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19838862
Conclusion of this study
This phase II study provides preliminary evidence of a possible therapeutic effect of saffron extract in the treatment of patients with mild-to-moderate Alzheimer's disease. This trial is registered with the Iranian Clinical Trials Registry (IRCT138711051556N1).
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study